Table 4.
Comparison of Replacement vs non-Replacement groups in the seven studies that incurred subject replacement.
| Variable | Statistic | Replacement | Overall | p-Value | |
|---|---|---|---|---|---|
| NO (n = 35) | YES (n = 12) | ||||
| FACT-G | Mean (SD)/N | 70.9 (14.6)/34 | 75.6 (14)/10 | 72 (14.5)/44 | 0.419 |
| Median (Range) | 70.2 (28.7, 93.3) | 77.4 (55.8, 93.3) | 72.6 (28.7, 93.3) | ||
| EORTC | Mean (SD)/N | 73.5 (15.1)/34 | 72.3 (20.9)/10 | 73.2 (16.3)/44 | 0.986 |
| Median (Range) | 74 (42.5, 93.9) | 79.9 (43.1, 96.9) | 75.8 (42.5, 96.9) | ||
| MOSSSS | Mean (SD)/N | 83.8 (17.8)/34 | 95.4 (6.6)/10 | 86.4 (16.6)/44 | 0.041 |
| Median (Range) | 90.1 (19.7, 100) | 98 (78.9, 100) | 91.4 (19.7, 100) | ||
| CCI | Mean (SD)/N | 8.2 (1.7)/35 | 9 (1.5)/12 | 8.4 (1.6)/47 | 0.121 |
| Median (Range) | 8 (3, 11) | 9 (6, 12) | 9 (3, 12) | ||
FACT-G: Baseline Functional Assessment of Cancer Therapy—General Score. EORTC: Baseline European Organization for Research and Treatment of Cancer QLQ-C30 Score. MOSSSS: Baseline Medical Outcomes Study Social Support Survey Score. CCI: Baseline Charlson Comorbidity Index.